Completed PHASE1 INTERVENTIONAL 1-arm NCT01241162

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

A Phase I Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed Neuroblastoma and Sarcoma.

Sponsor: Solving Kids' Cancer

Conditions Ewings Sarcoma Neuroblastoma Osteogenic Sarcoma Rhabdomyosarcoma Synovial Sarcoma

Interventions Autologous dendritic cell vaccine with adjuvant

Updated 7 times since 2017 Last updated: May 8, 2017 Started: Aug 31, 2010 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01241162, this PHASE1 trial focuses on Ewings Sarcoma and Neuroblastoma and remains completed. Sponsored by Solving Kids' Cancer, it has been updated 7 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2020 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Sep 2020 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Solving Kids' Cancer
University of Louisville

Data source: University of Louisville

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Louisville, United States